Skip to main content
Erschienen in: Cancer Causes & Control 12/2017

05.10.2017 | Original paper

Economic and disease burden of breast cancer associated with suboptimal breastfeeding practices in Mexico

verfasst von: Mishel Unar-Munguía, Rafael Meza, M. Arantxa Colchero, Gabriela Torres-Mejía, Teresita Gonzalez de Cosío

Erschienen in: Cancer Causes & Control | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Exclusive breastfeeding and longer breastfeeding reduce women’s breast cancer risk but Mexico has one of the lowest breastfeeding rates worldwide. We estimated the lifetime economic and disease burden of breast cancer in Mexico if 95% of parous women breastfeed each child exclusively for 6 months and continue breastfeeding for over a year.

Methods

We used a static microsimulation model with a cost-of-illness approach to simulate a cohort of Mexican women. We estimated breast cancer incidence, premature mortality, disability-adjusted life years (DALYs), medical costs, and income losses due to breast cancer and extrapolated the results to 1.116 million Mexican women of age 15 in 2012. Costs were expressed in 2015 US dollars and discounted at a 3% annual rate.

Results

We estimated that 2,186 premature deaths (95% CI 2,123–2,248), 9,936 breast cancer cases (95% CI 9,651–10,220), 45,109 DALYs (95% CI 43,000–47,217), and $245 million USD (95% CI 234–256) in medical costs and income losses owing to breast cancer could be saved over a cohort’s lifetime. Medical costs account for 80% of the economic burden; income losses and opportunity costs for caregivers account for 15 and 5%, respectively.

Conclusions

In Mexico, the burden of breast cancer due to suboptimal breastfeeding in women is high in terms of morbidity, premature mortality, and the economic costs for the health sector and society.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Unar-Munguía M, Torres-Mejía G, Colchero MA, González de Cosío T (2017) Breastfeeding mode and risk of breast cancer: a dose–response meta-analysis. J Hum Lact 33(2):422–434CrossRefPubMed Unar-Munguía M, Torres-Mejía G, Colchero MA, González de Cosío T (2017) Breastfeeding mode and risk of breast cancer: a dose–response meta-analysis. J Hum Lact 33(2):422–434CrossRefPubMed
3.
Zurück zum Zitat Victora CG, Bahl R, Barros AJ, Franca GV, Horton S, Krasevec J, Murch S, Sankar MJ, Walker N, Rollins NC, Lancet Breastfeeding Series Group (2016) Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387(10017):475–490. doi:10.1016/S0140-6736(15)01024-7 CrossRefPubMed Victora CG, Bahl R, Barros AJ, Franca GV, Horton S, Krasevec J, Murch S, Sankar MJ, Walker N, Rollins NC, Lancet Breastfeeding Series Group (2016) Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387(10017):475–490. doi:10.​1016/​S0140-6736(15)01024-7 CrossRefPubMed
4.
Zurück zum Zitat World Health Organization (2008) Indicators for assessing infant and young child feeding practices: conclusions of a consensus meeting held 6–8 November 2007 in Washington D.C., USA. World Health Organization (WHO) World Health Organization (2008) Indicators for assessing infant and young child feeding practices: conclusions of a consensus meeting held 6–8 November 2007 in Washington D.C., USA. World Health Organization (WHO)
5.
Zurück zum Zitat González de Cosío T, Escobar-Zaragoza L, González-Castell LD, Rivera-Dommarco JA (2013) Prácticas de alimentación infantil y deterioro de la lactancia materna en México. [Infant feeding practices and deterioration of breastfeeding in Mexico]. Salud Publica de México 55(2):S170–S179CrossRefPubMed González de Cosío T, Escobar-Zaragoza L, González-Castell LD, Rivera-Dommarco JA (2013) Prácticas de alimentación infantil y deterioro de la lactancia materna en México. [Infant feeding practices and deterioration of breastfeeding in Mexico]. Salud Publica de México 55(2):S170–S179CrossRefPubMed
6.
Zurück zum Zitat Torres-Sánchez LE, Rojas-Martínez R, Escamilla-Núñez C, Vara-Salazar EDL, Lazcano-Ponce E (2014) Tendencias en la mortalidad por cáncer en México de 1980 a 2011 [Cancer mortality trends in Mexico, 1980–2011]. Salud Pública de México 56(5):473–491CrossRefPubMed Torres-Sánchez LE, Rojas-Martínez R, Escamilla-Núñez C, Vara-Salazar EDL, Lazcano-Ponce E (2014) Tendencias en la mortalidad por cáncer en México de 1980 a 2011 [Cancer mortality trends in Mexico, 1980–2011]. Salud Pública de México 56(5):473–491CrossRefPubMed
7.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed
10.
Zurück zum Zitat Salomon JA, Carvalho N, Gutiérrez-Delgado C, Orozco R, Mancuso A, Hogan DR, Lee D, Murakami Y, Sridharan L, Medina-Mora ME (2012) Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. BMJ 344:e355CrossRefPubMedPubMedCentral Salomon JA, Carvalho N, Gutiérrez-Delgado C, Orozco R, Mancuso A, Hogan DR, Lee D, Murakami Y, Sridharan L, Medina-Mora ME (2012) Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. BMJ 344:e355CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Gutierrez JP, Hernandez-Avila M (2013) Cobertura de protección en salud y perfil de la población sin protección en México, 2000–2012. [Health protection coverage in Mexico, and profile of unprotected population 2000–2012]. Salud Publica de México 55(Suppl 2):S83–S90CrossRefPubMed Gutierrez JP, Hernandez-Avila M (2013) Cobertura de protección en salud y perfil de la población sin protección en México, 2000–2012. [Health protection coverage in Mexico, and profile of unprotected population 2000–2012]. Salud Publica de México 55(Suppl 2):S83–S90CrossRefPubMed
13.
Zurück zum Zitat Knaul FM, Arreola-Ornelas H, Velázquez E, Dorantes J, Méndez Ó, Ávila-Burgos L (2009) El costo de la atención médica del cáncer mamario: el caso del Instituto Mexicano del Seguro Social. [The health care costs of breast cancer: the case of the Mexican Social Security Institute]. Salud Pública de México 51(supplement 2):s286–s295CrossRefPubMed Knaul FM, Arreola-Ornelas H, Velázquez E, Dorantes J, Méndez Ó, Ávila-Burgos L (2009) El costo de la atención médica del cáncer mamario: el caso del Instituto Mexicano del Seguro Social. [The health care costs of breast cancer: the case of the Mexican Social Security Institute]. Salud Pública de México 51(supplement 2):s286–s295CrossRefPubMed
16.
Zurück zum Zitat Bartick MC, Stuebe AM, Schwarz EB, Luongo C, Reinhold AG, Foster EM (2013) Cost analysis of maternal disease associated with suboptimal breastfeeding. Obstet Gynecol 122(1):111–119CrossRefPubMed Bartick MC, Stuebe AM, Schwarz EB, Luongo C, Reinhold AG, Foster EM (2013) Cost analysis of maternal disease associated with suboptimal breastfeeding. Obstet Gynecol 122(1):111–119CrossRefPubMed
18.
Zurück zum Zitat Lawrence RA, Lawrence RM (2005) Breastfeeding: a guide for the medical profession, 6th edn. Elsevier Mosby, Philadelphia Lawrence RA, Lawrence RM (2005) Breastfeeding: a guide for the medical profession, 6th edn. Elsevier Mosby, Philadelphia
19.
Zurück zum Zitat Buchner F, Hoekstra J, Van Rossum C (2007) Health gain and economic evaluation of breastfeeding policies: model simulation. Dutch National Institute for Public Health and the Environment, Bilthoven Buchner F, Hoekstra J, Van Rossum C (2007) Health gain and economic evaluation of breastfeeding policies: model simulation. Dutch National Institute for Public Health and the Environment, Bilthoven
22.
Zurück zum Zitat Gold MR (1998) Standardizing cost-effectiveness analyses: the panel on cost-effectiveness in health and medicine. Acad Radiol 5(Suppl 2):S351–S354CrossRefPubMed Gold MR (1998) Standardizing cost-effectiveness analyses: the panel on cost-effectiveness in health and medicine. Acad Radiol 5(Suppl 2):S351–S354CrossRefPubMed
24.
Zurück zum Zitat Ángeles-Llerenas A, Torres-Mejía G, Lazcano-Ponce E, Uscanga-Sánchez S, Mainero-Ratchelous F, Hernández-Ávila JE, Morales-Carmona E, Hernández-Ávila M (2016) Effect of care-delivery delay on the survival of Mexican women with breast cancer. Salud Pública de México 58(2):237–250CrossRefPubMed Ángeles-Llerenas A, Torres-Mejía G, Lazcano-Ponce E, Uscanga-Sánchez S, Mainero-Ratchelous F, Hernández-Ávila JE, Morales-Carmona E, Hernández-Ávila M (2016) Effect of care-delivery delay on the survival of Mexican women with breast cancer. Salud Pública de México 58(2):237–250CrossRefPubMed
25.
Zurück zum Zitat Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S (2013) Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380(9859):2129–2143CrossRef Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S (2013) Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380(9859):2129–2143CrossRef
27.
Zurück zum Zitat Secretaría de Salud., Comisión Nacional de Protección Social en Salud. Tabulador del Fondo de Protección contra Gastos Catastróficos (FPGC), [Ministry of Health. National Commission for Social Protection in Health. Tabulator of the Protection Fund against Catastrophic Expenses] (2010) Secretaría de Salud., Comisión Nacional de Protección Social en Salud. Tabulador del Fondo de Protección contra Gastos Catastróficos (FPGC), [Ministry of Health. National Commission for Social Protection in Health. Tabulator of the Protection Fund against Catastrophic Expenses] (2010)
28.
Zurück zum Zitat Gutiérrez-Delgado C, Armas-Texta D, Reynoso-Noverón N, Meneses-García A, Mohar-Betancourt A (2016) Estimating the indirect costs associated with the expected number of cancer cases in Mexico by 2020. Salud Pública de México 58(2):228–236CrossRefPubMed Gutiérrez-Delgado C, Armas-Texta D, Reynoso-Noverón N, Meneses-García A, Mohar-Betancourt A (2016) Estimating the indirect costs associated with the expected number of cancer cases in Mexico by 2020. Salud Pública de México 58(2):228–236CrossRefPubMed
30.
Zurück zum Zitat Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, Blake-Cerda M, Arce C, Motola-Kuba D, Villarreal-Garza C, Gonzalez-Angulo AM, Bargallo E, Aguilar JL, Mohar A, Arrieta O (2011) Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 117(16):3658–3669. doi:10.1002/cncr.25961 CrossRefPubMed Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, Blake-Cerda M, Arce C, Motola-Kuba D, Villarreal-Garza C, Gonzalez-Angulo AM, Bargallo E, Aguilar JL, Mohar A, Arrieta O (2011) Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 117(16):3658–3669. doi:10.​1002/​cncr.​25961 CrossRefPubMed
31.
Zurück zum Zitat Amadou A, Torres-Mejia G, Hainaut P, Romieu I (2014) Breast cancer in Latin America: global burden, patterns, and risk factors. Salud Publica Mex 56(5):547–554CrossRefPubMed Amadou A, Torres-Mejia G, Hainaut P, Romieu I (2014) Breast cancer in Latin America: global burden, patterns, and risk factors. Salud Publica Mex 56(5):547–554CrossRefPubMed
32.
Zurück zum Zitat Secretaría de Salud, Unidad de Análisis Económico (2015) Impacto financiero del sobrepeso y obesidad en México 1999–2023. [Ministry of Health, Economic Analyses Unit. Financial impact of overweight and obesity in Mexico, 1999–2023] UAE-NT-001-2015. Secretaría de Salud, México Secretaría de Salud, Unidad de Análisis Económico (2015) Impacto financiero del sobrepeso y obesidad en México 1999–2023. [Ministry of Health, Economic Analyses Unit. Financial impact of overweight and obesity in Mexico, 1999–2023] UAE-NT-001-2015. Secretaría de Salud, México
33.
Zurück zum Zitat Gómez-Rico JA, Altagracia-Martínez M, Kravzov-Jinich J, Cárdenas-Elizalde R, Rubio-Poo C (2008) The costs of breast cancer in a Mexican public health institution. Risk Manag Healthc Policy 1:15PubMedPubMedCentral Gómez-Rico JA, Altagracia-Martínez M, Kravzov-Jinich J, Cárdenas-Elizalde R, Rubio-Poo C (2008) The costs of breast cancer in a Mexican public health institution. Risk Manag Healthc Policy 1:15PubMedPubMedCentral
34.
35.
Zurück zum Zitat Franco-Marina F, Lazcano-Ponce E, López-Carrillo L (2009) Breast cancer mortality in Mexico: an age-period-cohort analysis. Salud pública de México 51:s157–s164CrossRefPubMed Franco-Marina F, Lazcano-Ponce E, López-Carrillo L (2009) Breast cancer mortality in Mexico: an age-period-cohort analysis. Salud pública de México 51:s157–s164CrossRefPubMed
36.
Zurück zum Zitat Rippeyoung PL, Noonan MC (2012) Is breastfeeding truly cost free? Income consequences of breastfeeding for women. Am Sociol Rev 77(2):244–267CrossRef Rippeyoung PL, Noonan MC (2012) Is breastfeeding truly cost free? Income consequences of breastfeeding for women. Am Sociol Rev 77(2):244–267CrossRef
37.
Zurück zum Zitat Save the Children (2012) Nutrition in the first 1,000 days: State of the World’s Mothers 2012. Save the Children Fairfield Save the Children (2012) Nutrition in the first 1,000 days: State of the World’s Mothers 2012. Save the Children Fairfield
38.
Zurück zum Zitat Victora CG, Aquino EM, do Carmo Leal M, Monteiro CA, Barros FC, Szwarcwald CL (2011) Maternal and child health in Brazil: progress and challenges. Lancet 377(9780):1863–1876CrossRefPubMed Victora CG, Aquino EM, do Carmo Leal M, Monteiro CA, Barros FC, Szwarcwald CL (2011) Maternal and child health in Brazil: progress and challenges. Lancet 377(9780):1863–1876CrossRefPubMed
39.
Zurück zum Zitat González de Cosío-Martinez T, Hernández-Cordero S, Rivera-Dommarco J, Hernández-Ávila M (2017) Recomendaciones para una política nacional de promoción de la lactancia materna en México: postura de la Academia Nacional de Medicina [Recommendations for a multisectorial national policy to promote breastfeeding in Mexico: position of the National Academy of Medicine]. Salud Pública de México 59(1):106–113CrossRef González de Cosío-Martinez T, Hernández-Cordero S, Rivera-Dommarco J, Hernández-Ávila M (2017) Recomendaciones para una política nacional de promoción de la lactancia materna en México: postura de la Academia Nacional de Medicina [Recommendations for a multisectorial national policy to promote breastfeeding in Mexico: position of the National Academy of Medicine]. Salud Pública de México 59(1):106–113CrossRef
42.
Zurück zum Zitat Kramer MS, Chalmers B, Hodnett ED, Sevkovskaya Z, Dzikovich I, Shapiro S, Collet JP, Vanilovich I, Mezen I, Ducruet T, Shishko G, Zubovich V, Mknuik D, Gluchanina E, Dombrovskiy V, Ustinovitch A, Kot T, Bogdanovich N, Ovchinikova L, Helsing E, Group PS (2001) Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA 285(4):413–420CrossRefPubMed Kramer MS, Chalmers B, Hodnett ED, Sevkovskaya Z, Dzikovich I, Shapiro S, Collet JP, Vanilovich I, Mezen I, Ducruet T, Shishko G, Zubovich V, Mknuik D, Gluchanina E, Dombrovskiy V, Ustinovitch A, Kot T, Bogdanovich N, Ovchinikova L, Helsing E, Group PS (2001) Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA 285(4):413–420CrossRefPubMed
43.
Zurück zum Zitat Chapman DJ, Morel K, Anderson AK, Damio G, Perez-Escamilla R (2010) Breastfeeding peer counseling: from efficacy through scale-up. J Hum Lact 26(3):314–326CrossRefPubMedPubMedCentral Chapman DJ, Morel K, Anderson AK, Damio G, Perez-Escamilla R (2010) Breastfeeding peer counseling: from efficacy through scale-up. J Hum Lact 26(3):314–326CrossRefPubMedPubMedCentral
Metadaten
Titel
Economic and disease burden of breast cancer associated with suboptimal breastfeeding practices in Mexico
verfasst von
Mishel Unar-Munguía
Rafael Meza
M. Arantxa Colchero
Gabriela Torres-Mejía
Teresita Gonzalez de Cosío
Publikationsdatum
05.10.2017
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 12/2017
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0965-0

Weitere Artikel der Ausgabe 12/2017

Cancer Causes & Control 12/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.